SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million

Reuters
03/21
SMX FY 2025 net loss widens to USD 174.59 million as R&D expenses more than tripled to USD 11.23 million
  • SMX published an annual report on Form 20-F for the fiscal year ended Dec. 31, 2025.
  • The company reported no revenue and a net loss of USD 174.59 million.
  • Operating loss was USD 146.29 million, while general and administrative expenses were USD 120.1 million.
  • Research and development expenses were USD 11.23 million and selling and marketing expenses were USD 4.11 million.
  • Cash and cash equivalents were USD 12.2 million at year-end, and management said the financial statements include an explanatory paragraph about substantial doubt regarding the company’s ability to continue as a going concern.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMX (Security Matters) plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-011985), on March 20, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10